questionsmedicales.fr
Maladies cardiovasculaires
Maladies vasculaires
Embolie et thrombose
Thrombose
Thrombose veineuse
Thrombose veineuse profonde du membre supérieur
Thrombose veineuse profonde du membre supérieur : Questions médicales fréquentes
Termes MeSH sélectionnés :
Molecular Docking Simulation
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Thrombose veineuse profonde du membre supérieur : Questions médicales les plus fréquentes",
"headline": "Thrombose veineuse profonde du membre supérieur : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Thrombose veineuse profonde du membre supérieur : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-29",
"dateModified": "2025-04-25",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Thrombose veineuse profonde du membre supérieur"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Thrombose veineuse",
"url": "https://questionsmedicales.fr/mesh/D020246",
"about": {
"@type": "MedicalCondition",
"name": "Thrombose veineuse",
"code": {
"@type": "MedicalCode",
"code": "D020246",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.355.830.925"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Thrombose veineuse profonde du membre supérieur",
"alternateName": "Upper Extremity Deep Vein Thrombosis",
"code": {
"@type": "MedicalCode",
"code": "D056824",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Olivier Espitia",
"url": "https://questionsmedicales.fr/author/Olivier%20Espitia",
"affiliation": {
"@type": "Organization",
"name": "Department of Internal and Vascular Medicine."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Damon E Houghton",
"url": "https://questionsmedicales.fr/author/Damon%20E%20Houghton",
"affiliation": {
"@type": "Organization",
"name": "Gonda Vascular Center, Thrombophilia Clinic, Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA."
}
},
{
"@type": "Person",
"name": "Waldemar E Wysokinski",
"url": "https://questionsmedicales.fr/author/Waldemar%20E%20Wysokinski",
"affiliation": {
"@type": "Organization",
"name": "Gonda Vascular Center, Thrombophilia Clinic, Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA."
}
},
{
"@type": "Person",
"name": "Marc-Antoine Pistorius",
"url": "https://questionsmedicales.fr/author/Marc-Antoine%20Pistorius",
"affiliation": {
"@type": "Organization",
"name": "Department of Internal and Vascular Medicine."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors.",
"datePublished": "2022-08-26",
"url": "https://questionsmedicales.fr/article/36026508",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0268269"
}
},
{
"@type": "ScholarlyArticle",
"name": "Py-CoMFA, docking, and molecular dynamics simulations of Leishmania (L.) amazonensis arginase inhibitors.",
"datePublished": "2024-05-21",
"url": "https://questionsmedicales.fr/article/38773273",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-62520-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Exploring the molecular mechanism of ginseng against anthracycline-induced cardiotoxicity based on network pharmacology, molecular docking and molecular dynamics simulation.",
"datePublished": "2024-09-06",
"url": "https://questionsmedicales.fr/article/39243097",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s41065-024-00334-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Study of the antidiabetic mechanism of berberine compound on FOXO1 transcription factor through molecular docking and molecular dynamics simulations.",
"datePublished": "2024-07-09",
"url": "https://questionsmedicales.fr/article/38981921",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00894-024-06060-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Research advances of molecular docking and molecular dynamic simulation in recognizing interaction between muscle proteins and exogenous additives.",
"datePublished": "2023-07-08",
"url": "https://questionsmedicales.fr/article/37453331",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.foodchem.2023.136836"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies cardiovasculaires",
"item": "https://questionsmedicales.fr/mesh/D002318"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies vasculaires",
"item": "https://questionsmedicales.fr/mesh/D014652"
},
{
"@type": "ListItem",
"position": 4,
"name": "Embolie et thrombose",
"item": "https://questionsmedicales.fr/mesh/D016769"
},
{
"@type": "ListItem",
"position": 5,
"name": "Thrombose",
"item": "https://questionsmedicales.fr/mesh/D013927"
},
{
"@type": "ListItem",
"position": 6,
"name": "Thrombose veineuse",
"item": "https://questionsmedicales.fr/mesh/D020246"
},
{
"@type": "ListItem",
"position": 7,
"name": "Thrombose veineuse profonde du membre supérieur",
"item": "https://questionsmedicales.fr/mesh/D056824"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Thrombose veineuse profonde du membre supérieur - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Thrombose veineuse profonde du membre supérieur",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Thrombose veineuse profonde du membre supérieur",
"description": "Comment diagnostiquer une thrombose veineuse profonde ?\nQuels tests sanguins sont utiles ?\nQuels signes cliniques indiquent une thrombose ?\nQuand faire un scanner pour le diagnostic ?\nLa thrombose peut-elle être asymptomatique ?",
"url": "https://questionsmedicales.fr/mesh/D056824?mesh_terms=Molecular+Docking+Simulation&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Thrombose veineuse profonde du membre supérieur",
"description": "Quels sont les symptômes courants ?\nLa douleur est-elle toujours présente ?\nComment différencier une thrombose d'une blessure ?\nLes symptômes peuvent-ils varier ?\nY a-t-il des symptômes systémiques ?",
"url": "https://questionsmedicales.fr/mesh/D056824?mesh_terms=Molecular+Docking+Simulation&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Thrombose veineuse profonde du membre supérieur",
"description": "Comment prévenir la thrombose veineuse profonde ?\nLes bas de compression sont-ils utiles ?\nQuels médicaments peuvent prévenir la thrombose ?\nL'hydratation joue-t-elle un rôle ?\nLes exercices sont-ils importants ?",
"url": "https://questionsmedicales.fr/mesh/D056824?mesh_terms=Molecular+Docking+Simulation&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Thrombose veineuse profonde du membre supérieur",
"description": "Quels traitements sont disponibles ?\nQuand utiliser des thrombolytiques ?\nLa compression est-elle recommandée ?\nQuel suivi est nécessaire après traitement ?\nLes traitements sont-ils efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D056824?mesh_terms=Molecular+Docking+Simulation&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Thrombose veineuse profonde du membre supérieur",
"description": "Quelles sont les complications possibles ?\nComment l'embolie pulmonaire se produit-elle ?\nY a-t-il des risques à long terme ?\nLes complications sont-elles fréquentes ?\nComment prévenir les complications ?",
"url": "https://questionsmedicales.fr/mesh/D056824?mesh_terms=Molecular+Docking+Simulation&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Thrombose veineuse profonde du membre supérieur",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes femmes enceintes sont-elles à risque ?\nLe tabagisme est-il un facteur de risque ?\nLes maladies chroniques augmentent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D056824?mesh_terms=Molecular+Docking+Simulation&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une thrombose veineuse profonde ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un écho-Doppler veineux est souvent utilisé pour confirmer la présence d'un caillot."
}
},
{
"@type": "Question",
"name": "Quels tests sanguins sont utiles ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de D-dimères peuvent aider à évaluer la probabilité d'une thrombose."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une thrombose ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un gonflement, une douleur ou une rougeur dans le bras peuvent indiquer une thrombose."
}
},
{
"@type": "Question",
"name": "Quand faire un scanner pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un scanner peut être requis si l'échographie est inconclusive ou si des complications sont suspectées."
}
},
{
"@type": "Question",
"name": "La thrombose peut-elle être asymptomatique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent ne présenter aucun symptôme malgré la présence d'un caillot."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur, gonflement, chaleur et rougeur dans le bras affecté."
}
},
{
"@type": "Question",
"name": "La douleur est-elle toujours présente ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la douleur peut être légère ou absente, rendant le diagnostic difficile."
}
},
{
"@type": "Question",
"name": "Comment différencier une thrombose d'une blessure ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "La douleur d'une thrombose est souvent persistante et accompagnée de gonflement."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon la taille du caillot et la localisation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes systémiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fièvre peuvent survenir si une infection est présente."
}
},
{
"@type": "Question",
"name": "Comment prévenir la thrombose veineuse profonde ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une activité physique régulière et éviter l'immobilité prolongée aide à prévenir."
}
},
{
"@type": "Question",
"name": "Les bas de compression sont-ils utiles ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils aident à améliorer la circulation sanguine et à réduire le risque de thrombose."
}
},
{
"@type": "Question",
"name": "Quels médicaments peuvent prévenir la thrombose ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticoagulants peuvent être prescrits pour les patients à risque élevé de thrombose."
}
},
{
"@type": "Question",
"name": "L'hydratation joue-t-elle un rôle ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une bonne hydratation aide à fluidifier le sang et à prévenir la formation de caillots."
}
},
{
"@type": "Question",
"name": "Les exercices sont-ils importants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des exercices réguliers favorisent la circulation sanguine et réduisent le risque."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticoagulants sont le traitement principal pour dissoudre le caillot."
}
},
{
"@type": "Question",
"name": "Quand utiliser des thrombolytiques ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les thrombolytiques sont utilisés dans les cas graves pour dissoudre rapidement le caillot."
}
},
{
"@type": "Question",
"name": "La compression est-elle recommandée ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des bas de compression peuvent aider à réduire le gonflement et améliorer la circulation."
}
},
{
"@type": "Question",
"name": "Quel suivi est nécessaire après traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier est essentiel pour surveiller la résorption du caillot et prévenir les récidives."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avec un traitement approprié, la plupart des patients se rétablissent complètement."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'embolie pulmonaire, qui peut être mortelle si non traitée."
}
},
{
"@type": "Question",
"name": "Comment l'embolie pulmonaire se produit-elle ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un caillot peut se détacher et voyager vers les poumons, bloquant une artère pulmonaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques à long terme ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent développer un syndrome post-thrombotique avec douleur chronique."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications graves sont rares mais nécessitent une attention médicale rapide."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement précoce et un suivi régulier sont essentiels pour prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'immobilité prolongée, les antécédents de thrombose et certaines maladies."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de thrombose augmente avec l'âge, surtout après 60 ans."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes sont-elles à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la grossesse augmente le risque de thrombose en raison des changements hormonaux."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme augmente le risque de thrombose en affectant la circulation sanguine."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le cancer ou les maladies cardiaques augmentent le risque de thrombose."
}
}
]
}
]
}
Antimalarial drug resistance has thrown a spanner in the works of malaria elimination. New drugs are required for ancillary support of existing malaria control efforts. Plasmodium falciparum requires ...
Leishmaniasis is a disease caused by a protozoan of the genus Leishmania, affecting millions of people, mainly in tropical countries, due to poor social conditions and low economic development. First-...
Previous clinical and basic studies have revealed that ginseng might have cardioprotective properties against anthracycline-induced cardiotoxicity (AIC). However, the underlying mechanism of ginseng a...
Fourteen drug-disease common targets were identified. Enrichment analysis showed that the AGE-RAGE in diabetic complications, fluid shear stress and atherosclerosis, and TNF signaling pathway were pot...
This study suggested that ginseng might exert their protective effects against AIC through the derived effector compounds beta-Sitosterol, Kaempferol and Fumarine by targeting CCNA2, STAT1, and ICAM1,...
Diabetes mellitus (DM) is a metabolic disorder disease that causes hyperglycemia conditions and associated with various chronic complications leading to mortality. Due to high toxicity of conventional...
Docking between ligand and FOXO1 receptor was carried out with Autodock4.2. For molecular dynamics simulations, the force fields of DNA.OL15, protein.ff14SB, gaff2, and tip3p were used....
During storage and processing, muscle proteins, e.g. myosin and myoglobin, will inevitably undergo degeneration, which is thus accompanied by quality deterioration of muscle foods. Some exogenous addi...
Cereblon (CRBN) is a substrate receptor of E3 ubiquitin ligase as well as the target of thalidomide and lenalidomide, plays a vital role in endogenous protein degradation. In this article, two series ...
Direct oral anticoagulants are an important and relatively new class of synthetic anticoagulant drugs commonly used for the pharmacotherapy of thromboembolic disorders. However, they still have some l...
Cancer is a serious threat to human life and social development and the use of scientific methods for cancer prevention and control is necessary. In this study, HQSAR, CoMFA, CoMSIA and TopomerCoMFA m...
The pandemic of COVID-19 caused by SARS-CoV-2 has made a worldwide health emergency. Despite the fact that current vaccines are readily available, several SARSCoV-2 variants affecting the existing vac...
Oritavancin is a semi-synthetic lipoglycopeptide antibiotic primarily used to treat serious infections caused by Gram-positive bacteria. The aim of this study was to elucidate possible molecular targe...
Computational methods were used in this study which include target prediction, molecular docking, molecular dynamics simulation, pharmacokinetics prediction, and physiological-based pharmacokinetics (...
Oritavancin was moderately soluble in water and did not permeate the blood-brain barrier. Seven molecular targets were identified in humans. Molecular docking results showed highest binding affinity o...
This comprehensive computational study has provided invaluable insights into the pharmacological profile of Oritavancin, aiding its further development and optimization for clinical use....